These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16378265)

  • 1. Australia: the N of 1 trial, an underappreciated research method.
    Rodnick JE
    Fam Med; 2006 Jan; 38(1):63. PubMed ID: 16378265
    [No Abstract]   [Full Text] [Related]  

  • 2. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methylphenidate double-blind trial: indication and performing].
    Bliznakova L; Gerstner S; Schmidt MH; Becker K
    Klin Padiatr; 2007; 219(1):9-16. PubMed ID: 17205427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 6. Using n-of-1 trials as a clinical tool to improve prescribing.
    Nikles CJ; Clavarino AM; Del Mar CB
    Br J Gen Pract; 2005 Mar; 55(512):175-80. PubMed ID: 15808031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An 8-year follow-up study of profiles and predictors of methylphenidate use in a nationwide sample of boys.
    Romano E; Thornhill S; Lacourse E
    J Pediatr; 2009 Nov; 155(5):721-7. PubMed ID: 19643442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.
    Yelland MJ; Nikles CJ; McNairn N; Del Mar CB; Schluter PJ; Brown RM
    Rheumatology (Oxford); 2007 Jan; 46(1):135-40. PubMed ID: 16777855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it truly random?
    Markey P
    Aust Fam Physician; 1999 Jan; 28 Suppl 1():S48. PubMed ID: 9988931
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving decision making in the treatment of ADHD.
    Vitiello B
    Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
    [No Abstract]   [Full Text] [Related]  

  • 12. N of 1 trials. Practical tools for medication management.
    Nikles CJ; Glasziou PP; Del Mar CB; Duggan CM; Mitchell G
    Aust Fam Physician; 2000 Nov; 29(11):1108-12. PubMed ID: 11127076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
    Corkum P; Panton R; Ironside S; Macpherson M; Williams T
    J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
    Levin FR; Evans SM; Brooks DJ; Garawi F
    Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
    Polzer J; Bangs ME; Zhang S; Dellva MA; Tauscher-Wisniewski S; Acharya N; Watson SB; Allen AJ; Wilens TE
    Biol Psychiatry; 2007 Mar; 61(5):713-9. PubMed ID: 16996485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].
    Kiliç BG; Bilgiç A; Gürkan K; Aysev A
    Turk Psikiyatri Derg; 2007; 18(3):207-13. PubMed ID: 17853975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of methylphenidate on working memory components: influence of measurement.
    Bedard AC; Jain U; Johnson SH; Tannock R
    J Child Psychol Psychiatry; 2007 Sep; 48(9):872-80. PubMed ID: 17714372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.